$BPTH
BIO-PATH HOLDINGS, INC.

2016 Q1 Form 10-Q Financial Statement

#000114420416100471 Filed on May 10, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $850.0K $790.0K
YoY Change 7.59% 107.89%
% of Gross Profit
Research & Development $1.020M $593.0K
YoY Change 72.01% 450.91%
% of Gross Profit
Depreciation & Amortization $10.00K $10.00K
YoY Change 0.0%
% of Gross Profit
Operating Expenses $1.869M $1.379M
YoY Change 35.53% 170.28%
Operating Profit -$1.869M -$1.379M
YoY Change 35.53% 170.28%
Interest Expense $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $2.000K $4.000K
YoY Change -50.0% -25.01%
Pretax Income -$1.870M -$1.370M
YoY Change 36.5% 174.0%
Income Tax
% Of Pretax Income
Net Earnings -$1.867M -$1.375M
YoY Change 35.78% 172.34%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$4.156M -$3.044M
COMMON SHARES
Basic Shares Outstanding 89.76M shares 89.76M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.470M $12.45M
YoY Change -48.03% -25.98%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $1.360M $480.0K
YoY Change 183.33% 204.83%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $7.830M $12.94M
YoY Change -39.49% -24.88%
LONG-TERM ASSETS
Property, Plant & Equipment $62.00K $102.8K
YoY Change -39.71%
Goodwill
YoY Change
Intangibles $1.050M $1.211M
YoY Change -13.28% -11.71%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.116M $1.310M
YoY Change -14.81% -4.47%
TOTAL ASSETS
Total Short-Term Assets $7.830M $12.94M
Total Long-Term Assets $1.116M $1.310M
Total Assets $8.946M $14.25M
YoY Change -37.22% -23.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $201.0K $80.00K
YoY Change 151.25% -66.39%
Accrued Expenses $699.0K $539.7K
YoY Change 29.52% 584.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $900.0K $616.2K
YoY Change 46.05% 46.74%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $900.0K $616.2K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $900.0K $616.2K
YoY Change 46.05% 46.74%
SHAREHOLDERS EQUITY
Retained Earnings -$27.25M
YoY Change
Common Stock $89.76K
YoY Change 0.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.050M $13.63M
YoY Change
Total Liabilities & Shareholders Equity $8.950M $14.25M
YoY Change -37.19% -23.38%

Cashflow Statement

Concept 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income -$1.867M -$1.375M
YoY Change 35.78% 172.34%
Depreciation, Depletion And Amortization $10.00K $10.00K
YoY Change 0.0%
Cash From Operating Activities -$2.380M -$1.410M
YoY Change 68.79% 158.99%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -2.380M -1.410M
Cash From Investing Activities
Cash From Financing Activities 0.000
Net Change In Cash -2.380M -1.410M
YoY Change 68.79% -110.63%
FREE CASH FLOW
Cash From Operating Activities -$2.380M -$1.410M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2016Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
40000 USD
CY2016Q1 us-gaap Depreciation
Depreciation
10000 USD
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
51000 USD
CY2016Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
61000 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
51000 USD
CY2016Q1 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
2500000 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
593000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1869000 USD
CY2016Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000 USD
CY2015Q1 us-gaap Revenues
Revenues
0 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
786000 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
1379000 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1379000 USD
CY2015Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
4000 USD
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-1375000 USD
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2016Q1 us-gaap Revenues
Revenues
0 USD
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1020000 USD
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
849000 USD
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
1869000 USD
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-1867000 USD
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
89763 shares
CY2015Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
2500000 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
883000 USD
CY2015Q4 us-gaap Assets
Assets
10755000 USD
CY2016Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
201000 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
54000 USD
CY2016Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1450000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1410000 USD
CY2016Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q1 us-gaap Assets
Assets
8946000 USD
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27251000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25384000 USD
CY2016Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
699000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
937000 USD
CY2016Q1 us-gaap Liabilities
Liabilities
900000 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
123000 USD
CY2016Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
123000 USD
CY2014Q4 us-gaap Cash
Cash
13859000 USD
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
89763 shares
CY2016Q1 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-2381000 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.45 pure
CY2016Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
571000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-37000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2381000 USD
CY2015Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
40000 USD
CY2015Q1 us-gaap Depreciation
Depreciation
10000 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
204000 USD
CY2015Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
22000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
54000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1405000 USD
CY2015Q1 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-1405000 USD
CY2015Q1 us-gaap Cash
Cash
12454000 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
92000 USD
CY2016Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
200000 USD
CY2015Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
100000 USD
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
89762872 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0149 pure
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.08 pure
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0174 pure
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2016Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1050000 USD
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1090000 USD
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
62000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
72000 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
89762872 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
89762872 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
89762872 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5752000 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
150000 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5902000 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5166000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.05
CY2016Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.40
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.06
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.99
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100000 USD
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100000 USD
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
9100000 USD
CY2016Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
100000 USD
CY2016Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
300000 USD
CY2016Q1 bpth Drug Product Testing Agreement Consideration To Be Paid In Stages
DrugProductTestingAgreementConsiderationToBePaidInStages
500000 USD
CY2015Q1 bpth Drug Product Testing Agreement Consideration To Be Paid In Stages
DrugProductTestingAgreementConsiderationToBePaidInStages
600000 USD
CY2016Q1 bpth Drug Supplier Commitments Development
DrugSupplierCommitmentsDevelopment
100000 USD

Files In Submission

Name View Source Status
0001144204-16-100471-index-headers.html Edgar Link pending
0001144204-16-100471-index.html Edgar Link pending
0001144204-16-100471.txt Edgar Link pending
0001144204-16-100471-xbrl.zip Edgar Link pending
bpth-20160331.xml Edgar Link completed
bpth-20160331.xsd Edgar Link pending
bpth-20160331_cal.xml Edgar Link unprocessable
bpth-20160331_def.xml Edgar Link unprocessable
bpth-20160331_lab.xml Edgar Link unprocessable
bpth-20160331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v438968_10q.htm Edgar Link pending
v438968_ex31.htm Edgar Link pending
v438968_ex32.htm Edgar Link pending